European Heart Journal Advance Access originally published online on November 22, 2006
European Heart Journal 2007 28(10):1186; doi:10.1093/eurheartj/ehl395
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The European Society of Cardiology 2007. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org
Value of cardiovascular magnetic resonance for determining cardiac involvement in systemic amyloidosis
Cardiovascular Magnetic Resonance Unit, Royal Brompton Hospital, Sydney Street, London SW3 6NP, UK
* Corresponding author. Tel: +44 20 7351 8812; fax: +44 20 7351 8816. E-mail address: s.prasad@rbht.nhs.uk
| The first 10% of the full text of this article appears below. |
A 66-year-old woman presented with atypical chest pain, symptoms of heart failure (NYHA class III), and loss of appetite. Her past medical history was notable for previous episode of decompensated heart failure and two transient cerebral ischaemic attacks.